Literature DB >> 22090449

Induction of serine protease inhibitor 9 by Mycobacterium tuberculosis inhibits apoptosis and promotes survival of infected macrophages.

Zahra Toossi1, Mianda Wu, Roxana Rojas, Barbara Kalsdorf, Htin Aung, Christina S Hirsch, Jessica Walrath, Angela Wolbink, Marieke van Ham, Richard F Silver.   

Abstract

Our recent microarray analysis of infected human alveolar macrophages (AMs) found serine protease inhibitor 9 (PI-9) to be the most prominently expressed of a cluster of apoptosis-associated genes induced by virulent Mycobacterium tuberculosis. In the current study, we show that induction of PI-9 occurs within hours of infection with M. tuberculosis H37Rv and is maintained through 7 days of infection in both AMs and blood monocytes. Inhibition of PI-9 by small inhibitory RNA decreased M. tuberculosis-induced expression of the antiapoptotic molecule Bcl-2 and resulted in a corresponding increase in production of caspase 3, a terminal effector molecule of apoptosis. Further, PI-9 small inhibitory RNA mediated a significant reduction in the subsequent survival of M. tuberculosis within AMs. Thus PI-9 induction within human mononuclear phagocytes by virulent M. tuberculosis serves to protect these primary targets of infection from elimination by apoptosis and thereby promotes intracellular survival of the organism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22090449      PMCID: PMC3242743          DOI: 10.1093/infdis/jir697

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  27 in total

1.  Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages.

Authors:  J Keane; H G Remold; H Kornfeld
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

2.  An increase in expression of a Mycobacterium tuberculosis mycolyl transferase gene (fbpB) occurs early after infection of human monocytes.

Authors:  R J Wilkinson; L E DesJardin; N Islam; B M Gibson; R A Kanost; K A Wilkinson; D Poelman; K D Eisenach; Z Toossi
Journal:  Mol Microbiol       Date:  2001-02       Impact factor: 3.501

3.  The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites.

Authors:  B A Bladergroen; M C Strik; N Bovenschen; O van Berkum; G L Scheffer; C J Meijer; C E Hack; J A Kummer
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

Review 4.  Macrophage apoptosis in mycobacterial infections.

Authors:  C Fratazzi; R D Arbeit; C Carini; M K Balcewicz-Sablinska; J Keane; H Kornfeld; H G Remold
Journal:  J Leukoc Biol       Date:  1999-11       Impact factor: 4.962

5.  Increased Bcl-2 and reduced Bax expression in infected macrophages in slowly progressive primary murine Mycobacterium tuberculosis infection.

Authors:  S J Mogga; T Mustafa; L Sviland; R Nilsen
Journal:  Scand J Immunol       Date:  2002-10       Impact factor: 3.487

6.  Modulators of inflammation use nuclear factor-kappa B and activator protein-1 sites to induce the caspase-1 and granzyme B inhibitor, proteinase inhibitor 9.

Authors:  Padma Kannan-Thulasiraman; David J Shapiro
Journal:  J Biol Chem       Date:  2002-08-12       Impact factor: 5.157

7.  Apoptosis genes in human alveolar macrophages infected with virulent or attenuated Mycobacterium tuberculosis: a pivotal role for tumor necrosis factor.

Authors:  Avrum Spira; J David Carroll; Gang Liu; Zeeshan Aziz; Vishal Shah; Hardy Kornfeld; Joseph Keane
Journal:  Am J Respir Cell Mol Biol       Date:  2003-05-14       Impact factor: 6.914

8.  Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic Bcl-2 family member Mcl-1.

Authors:  Laura M Sly; Suzanne M Hingley-Wilson; Neil E Reiner; W Robert McMaster
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

9.  Role of cellular activation and tumor necrosis factor-alpha in the early expression of Mycobacterium tuberculosis 85B mRNA in human alveolar macrophages.

Authors:  Najmul Islam; Andrew R Kanost; Luciella Teixeira; John Johnson; Rana Hejal; Htin Aung; Robert J Wilkinson; Christina S Hirsch; Zahra Toossi
Journal:  J Infect Dis       Date:  2004-06-18       Impact factor: 5.226

10.  The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells.

Authors:  J L Young; G K Sukhova; D Foster; W Kisiel; P Libby; U Schönbeck
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

View more
  6 in total

1.  HIV-1 and the immune response to TB.

Authors:  Naomi F Walker; Graeme Meintjes; Robert J Wilkinson
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831

2.  Role of protease inhibitor 9 in survival and replication of Mycobacterium tuberculosis in mononuclear phagocytes from HIV-1-infected patients.

Authors:  Zahra Toossi; Mianda Wu; Shigou Liu; Christina S Hirsch; Jessica Walrath; Marieke van Ham; Richard F Silver
Journal:  AIDS       Date:  2014-03-13       Impact factor: 4.177

3.  Mycobacteria exploit nitric oxide-induced transformation of macrophages into permissive giant cells.

Authors:  Kourosh Gharun; Julia Senges; Maximilian Seidl; Anne Lösslein; Julia Kolter; Florens Lohrmann; Manfred Fliegauf; Magdeldin Elgizouli; Marco Alber; Martina Vavra; Kristina Schachtrup; Anna L Illert; Martine Gilleron; Carsten J Kirschning; Antigoni Triantafyllopoulou; Philipp Henneke
Journal:  EMBO Rep       Date:  2017-11-02       Impact factor: 8.807

4.  Short communication: circulating plasma HIV-1 viral protein R in dual HIV-1/tuberculosis infection.

Authors:  Zahra Toossi; Shigou Liu; Mianda Wu; Harriet Mayanja-Kizza; Christina S Hirsch
Journal:  AIDS Res Hum Retroviruses       Date:  2014-06-10       Impact factor: 2.205

5.  Intracellular growth of Mycobacterium avium subspecies and global transcriptional responses in human macrophages after infection.

Authors:  Angelika Agdestein; Anya Jones; Arnar Flatberg; Tone B Johansen; Inger Austrheim Heffernan; Berit Djønne; Anthony Bosco; Ingrid Olsen
Journal:  BMC Genomics       Date:  2014-01-23       Impact factor: 3.969

6.  MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets.

Authors:  A Kurioka; J E Ussher; C Cosgrove; C Clough; J R Fergusson; K Smith; Y-H Kang; L J Walker; T H Hansen; C B Willberg; P Klenerman
Journal:  Mucosal Immunol       Date:  2014-10-01       Impact factor: 7.313

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.